Trial intelligence / Profile preview

Study of TRH in Patients With Thyroid or Pituitary Abnormalities

NCT00054756Phase 2Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Feb 2003
Primary completion
Sep 2014
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of thyrotropin-releasing hormone in thyroid disease, pituitary gland disorder, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Feb 2003; status: completed.

02

Drugs

thyrotropin-releasing hormone
03

Conditions

thyroid diseasepituitary gland disorder

Beyond the preview

Go deeper on NCT00054756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00054756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call